Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...

To read more about the latest highlights related to the PDC market, get a snapshot of the key highlights entailed in the ...

Having already acquired UK-based Cambridge Antibody Technology in 2006 ... After rejecting Pfizer, AstraZeneca continued with its own M&A ambitions, and in the following years the company saw ...

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...

The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

An antibody that can bind to many different types of influenza virus prevented macaques from getting seriously sick, and dying, from a highly pathogenic strain of H5N1 bird flu. The findings could ...

Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.

Select listed pharmaceuticals companies including Pfizer Ltd, Novartis India Ltd, AstraZeneca Pharma India Ltd and GSK Pharmaceuticals Ltd shall be the beneficiaries of the budget announcements ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

In 2000, the Union for International Cancer Control (UICC) named Feb. | In 2000, the Union for International Cancer Control named Feb. 4 World Cancer Day, with a goal of raising awareness of cancer ...